Mitchell Liu

Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial

David A. Palma, Robert Olson, Stephen Harrow et al. · The Lancet · 2019 · 1.8K citations

Open-label Trial, Radiation Therapy, Medicine +7

Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial

David A. Palma, Robert Olson, Stephen Harrow et al. · Journal of Clinical Oncology · 2020 · 1.2K citations · Full text

Stereotactic body radiotherapy versus conventional external beam radiotherapy in patients with painful spinal metastases: an open-label, multicentre, randomised, controlled, phase 2/3 trial

Arjun Sahgal, Sten Myrehaug, Shankar Siva et al. · The Lancet Oncology · 2021 · 378 citations

Radiation Therapy, Painful Spinal Metastases, Pain Medicine +10

Stereotactic ablative radiotherapy for comprehensive treatment of oligometastatic tumors (SABR-COMET): Study protocol for a randomized phase II trial

David A. Palma, Cornelis J.A. Haasbeek, George Rodrigues et al. · BMC Cancer · 2012 · 306 citations · Full text

Stereotactic Radiation for the Comprehensive Treatment of Oligometastases (SABR-COMET): Extended Long-Term Outcomes

Stephen Harrow, David A. Palma, Robert Olson et al. · International Journal of Radiation Oncology*Biology*Physics · 2022 · 189 citations · Full text

Comprehensive Treatment, Radiation Medicine, Radiopharmaceutical Therapy +5